<DOC>
	<DOCNO>NCT03007589</DOCNO>
	<brief_summary>The purpose study ass sunscreen sun protection fabric perform natural sunlight compare label claim , indoor test method ( exist modify ) instruction .</brief_summary>
	<brief_title>Natural Sunlight Protection Simulated Sunlight Protection Offered Sunscreens Fabrics</brief_title>
	<detailed_description>To evaluate difference level erythema persistent pigment darken sun protection follow single period natural sunlight exposure laboratory solar simulator exposure afford application sunscreen , use fabric , use pas glass filter .</detailed_description>
	<mesh_term>Sunburn</mesh_term>
	<mesh_term>Sunscreening Agents</mesh_term>
	<criteria>1 . Fitzpatrick Type I , II , III , IV V type skin . 2 . Must able expose natural sunlight 4 hour prone position 3 . Able read , write , speak understand English language . 4 . Has personally read , sign , date Informed Consent Form ( include HIPAA disclosure ) Photograph Release 5 . Generally good health base medical history report subject 6 . Healthy male female subject history evidence clinically relevant medical disorder , determine brief medical history interview . 7 . Willing able follow study instruction , include : Remain outdoors expose sun laboratory 4 hour Day 1 study expose skin back protect sunscreen fabric Apply specific sunscreen fabric designate site back lie motionless . No visual sign recent sun exposure back . No sunscreens lotion recently use back . Attend schedule visit intend successfully complete study Stay sun stay indoors sun exposure observation Day 2 . Women discourage use bra applies pressure skin site area may make difficult assess erythema PPD Day 2 . Refrain use sunscreen product tan bed use duration study . 1 . Individuals know allergy sensitivity sunscreens ingredient contain test product common topical skincare product , include adhesive . 2 . Perceptible erythema , PPD back determine PI designee . 3 . Women know pregnant nursing . 4 . Individuals disease condition skin ( e.g. , active [ i.e . flare ] eczema psoriasis , skin cancer , atypical nevus , polymorphic light eruption ( PMLE ) , porphyria , systemic lupus erythematous ( SLE ) , xeroderma pigmentosa ( XP ) ) could interfere study increase risk subject . 5 . Individuals selfreported UNCONTROLLED metabolic condition , diabetes , hypertension , hyper/hypothyroidism , hypercholesterolemia 6 . Subjects take medication chronic condition may make subject sun sensitive ( e.g. , Tetracyclines , antifungal , certain diuretic , etc . ) 7 . Skin diseases test site ( e.g. , photosensitivity disorder , etc . ) , may influence outcome study 8 . An individual condition PI 's judgment make candidate inappropriate subject study participation 9 . Individuals condition situation , PI 's opinion , may put subject significant risk , may confound study result , may interfere significantly subject 's participation study 10 . Individual view PI able complete study</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>erythema</keyword>
	<keyword>persistent pigment darken</keyword>
	<keyword>sunburn</keyword>
	<keyword>suntan</keyword>
</DOC>